FindTrial
Sign In

Human Papilloma Virus in Head and Neck Cancer: Clinico-pathological Outcome

HPV in Head Neck Squamous Cell Carcinoma (HN-SCC) - Clinico- Pathologic management correlation : An Observational Study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/04/003525
Enrollment
150
Registered
2013-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Head and Neck Cancers - HPV presence and viral load estimstion

Interventions

None listed

Sponsors

Cancer Centre Welfare Home and Research Institute
Lead Sponsor
National Institute of Biomedical Genomics
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All patients diagnosed as suffering from HNSCC presenting in the Institute

Exclusion criteria

Exclusion criteria: 1) Immunocompromised patients: a) Previous chemotherapy due to any cancer b) Immunodeficiency status-latrogenic or disease indused 2) Previous Radiotherapy due to any cause 3) Where adequate biopsy sample cannot be obtained due to technical reasons

Design outcomes

Primary

MeasureTime frame
HPV type and load related differences in disease progression and treatment response in HNSCCTimepoint: 3 years of recruitment followed by further 2 yrs of of follow up after the last recruitment.—

Secondary

MeasureTime frame
Site of Recurrence and time interval of recurrence following treatment of HNSCC dependant on HPV Subtype and viral load.Timepoint: 3 years of recruitment followed by further 2-5 yrs of of follow up after the last recruitment.—

Countries

India

Contacts

Public ContactDr Samir Bhattacharyya

Saroj Gupta Cancer Centre and Research Institute

singhdocinder@gmail.com9831142992

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026